Laura Gault

Insider Reports History

Location
Cambridge, MA
Signature
Brandon Marsh, attorney in fact for Laura Gault
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Gault:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Medical Officer Common Stock 34,649 $248,780 $7.18 13 Feb 2025 Direct
Sage Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 22,500 13 Feb 2024 Direct

Insider Reports Filed by Laura Gault

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SAGE Sage Therapeutics, Inc. 13 Feb 2025 1 -$4,918 4 Chief Medical Officer 14 Feb 2025, 16:26
SAGE Sage Therapeutics, Inc. 16 Jan 2025 1 $0 4 Chief Medical Officer 21 Jan 2025, 16:11
SAGE Sage Therapeutics, Inc. 05 Aug 2024 2 -$29,460 4 Chief Medical Officer 07 Aug 2024, 16:05
SAGE Sage Therapeutics, Inc. 13 Feb 2024 2 $0 4 Chief Medical Officer 15 Feb 2024, 17:02
SAGE Sage Therapeutics, Inc. 13 Feb 2023 1 $0 4 Chief Medical Officer 15 Feb 2023, 15:47
SAGE Sage Therapeutics, Inc. 01 Nov 2022 1 $0 4 Chief Medical Officer 01 Nov 2022, 17:30
SAGE Sage Therapeutics, Inc. 31 Oct 2022 0 $0 3 Chief Medical Officer 01 Nov 2022, 17:30